Jose Manuel De Maria Prieto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jose Manuel De Maria Prieto has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
A. Loscos
Department of Microbiology, Faculty of Medicine, Complutense University, Madrid, Spain
1 shared publicationC. Ramos
Department of Microbiology, Faculty of Medicine, Complutense University, Madrid, Spain
1 shared publicationF. Minguez
Department of Microbiology, Faculty of Medicine, Complutense University, Madrid, Spain
1 shared publication- Gabriel Oliver
Department of Orthopaedic Surgery Bellvitge University Hospital, Barcelona University, Hospitalet de Llobregat Barcelona Spain
1 shared publication Herman Johal
Affiliation Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada
1 shared publication- Jason Walter Busse
Department of Anesthesia, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 16 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0317485
Reasons for declining to participate in a trial of online cognitive behavioural therapy following orthopaedic trauma: A mixed methods study
The timely enrollment of study participants is critical to the success of clinical trials. Understanding factors that contribute to patients’ decision to participate in trials involving online cognitive behavioural therapy for pain management should prove helpful to optimize the design of study protocols. Fracture patients from an orthopaedic clinic who declined to participate in the Cognitive behavioural therapy to Optimize Post-operative rEcovery (COPE) trial were asked to complete a Research Participation Questionnaire that asked them about their previous experiences with clinical research and mental health therapy and their reasons for declining to participate in the COPE trial. At the end of the questionnaire, a subset of participants was offered the opportunity to participate in a telephone interview to further discuss why they declined to participate in the COPE trial. Sixty-four patients who declined to participate in the COPE trial completed the questionnaire and twenty of these participants agreed to take part in a telephone interview (31%). Twenty-two participants (34%) had previous experience with clinical research and six participants (9%) had received cognitive behavioural therapy (CBT) in the past. Excessive time commitment (41%) was the most commonly selected reason for not participating in the COPE trial, followed by a disinclination to participate in clinical research (19%). Four themes emerged from the interviews with participants: 1) belief that they could overcome mental health challenges after their fracture without external help; 2) belief that CBT might be helpful for some fracture patients, but not for themselves; 3) preference for online or in-person CBT; and 4) concerns regarding time commitment. To maximize enrollment, trials exploring the role of psychotherapy in recovery from orthopedic trauma should optimize time commitment of psychotherapy. Providing information in the patient consent process regarding evidence for psychotherapy and recovery from orthopedic trauma may also prove helpful in promoting patient enrollment.
- 16 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0317485
Open AccessReasons for declining to participate in a trial of online cognitive behavioural therapy following orthopaedic trauma: A mixed methods study
The timely enrollment of study participants is critical to the success of clinical trials. Understanding factors that contribute to patients’ decision to participate in trials involving online cognitive behavioural therapy for pain management should prove helpful to optimize the design of study protocols. Fracture patients from an orthopaedic clinic who declined to participate in the Cognitive behavioural therapy to Optimize Post-operative rEcovery (COPE) trial were asked to complete a Research Participation Questionnaire that asked them about their previous experiences with clinical research and mental health therapy and their reasons for declining to participate in the COPE trial. At the end of the questionnaire, a subset of participants was offered the opportunity to participate in a telephone interview to further discuss why they declined to participate in the COPE trial. Sixty-four patients who declined to participate in the COPE trial completed the questionnaire and twenty of these participants agreed to take part in a telephone interview (31%). Twenty-two participants (34%) had previous experience with clinical research and six participants (9%) had received cognitive behavioural therapy (CBT) in the past. Excessive time commitment (41%) was the most commonly selected reason for not participating in the COPE trial, followed by a disinclination to participate in clinical research (19%). Four themes emerged from the interviews with participants: 1) belief that they could overcome mental health challenges after their fracture without external help; 2) belief that CBT might be helpful for some fracture patients, but not for themselves; 3) preference for online or in-person CBT; and 4) concerns regarding time commitment. To maximize enrollment, trials exploring the role of psychotherapy in recovery from orthopedic trauma should optimize time commitment of psychotherapy. Providing information in the patient consent process regarding evidence for psychotherapy and recovery from orthopedic trauma may also prove helpful in promoting patient enrollment.
- 3 January 2024
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 32 (1) , 95-102
Economic evaluation of high tibial osteotomy: Closing wedge is more cost‐effective than open wedge technique when analysing the KOOS‐12 improvement
Purpose: The purpose of this study was to compare the cost‐effectiveness of two techniques for performing a knee valgus osteotomy: opening wedge high tibial osteotomy (OW‐HTO) vs closing wedge high tibial osteotomy (CW‐HTO).Methods: In this economic evaluation study, a cost‐effectiveness analysis from the perspective of the Spanish public healthcare system was performed, comparing OW‐HTO with CW‐HTO. All patients with medial knee osteoarthritis who underwent one of these procedures between 2018 and 2020 in our institution were included. The cost analysis included operating room, implant, graft and hospital admission costs. Functional outcomes (KOOS‐12, Tegner activity scale, pain and satisfaction) and radiological outcomes (hip‐knee‐ankle angle, medial proximal tibial angle, tibial slope and patellar height) were analysed. The cost‐effectiveness ratio was obtained by calculating the cost of improving the minimal clinically important difference (MCID) of KOOS‐12 for each procedure. All costs are expressed in 2020 euros.Results: Fifty‐one patients met the inclusion criteria (27 OW‐HTO and 24 CW‐HTO). Good to excellent functional outcomes, significant pain reduction (>6 points) and high patient satisfaction (>9/10) were observed in both groups. Both techniques yielded excellent radiological outcomes. N.s. differences in functional or radiological outcomes improvements between both procedures were found. However, the OW‐HTO group presented a higher total cost than the CW‐HTO group (4612.1 ± 765.6€ vs. 1827.1 ± 701.9€; p < 0.001). The cost‐effectiveness ratio was 818.1 ± 46.8 €/MCID for the CW‐HTO procedure and 2414.3 ± 115.2 €/MCID for the OW‐HTO procedure (p = 0.025).Conclusion: The CW‐HTO procedure presented a cost‐effectiveness ratio almost three times lower than the OW‐HTO procedure. Both techniques allowed to achieve of good to excellent functional outcomes, significant pain reduction and high patient satisfaction while correcting the varus limb malalignment and the metaphyseal tibial varus in patients with medial compartment osteoarthritis.Level of Evidence: Level III; economic study.
- 3 January 2024
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 32 (1) , 95-102
Economic evaluation of high tibial osteotomy: Closing wedge is more cost‐effective than open wedge technique when analysing the KOOS‐12 improvement
Purpose: The purpose of this study was to compare the cost‐effectiveness of two techniques for performing a knee valgus osteotomy: opening wedge high tibial osteotomy (OW‐HTO) vs closing wedge high tibial osteotomy (CW‐HTO).Methods: In this economic evaluation study, a cost‐effectiveness analysis from the perspective of the Spanish public healthcare system was performed, comparing OW‐HTO with CW‐HTO. All patients with medial knee osteoarthritis who underwent one of these procedures between 2018 and 2020 in our institution were included. The cost analysis included operating room, implant, graft and hospital admission costs. Functional outcomes (KOOS‐12, Tegner activity scale, pain and satisfaction) and radiological outcomes (hip‐knee‐ankle angle, medial proximal tibial angle, tibial slope and patellar height) were analysed. The cost‐effectiveness ratio was obtained by calculating the cost of improving the minimal clinically important difference (MCID) of KOOS‐12 for each procedure. All costs are expressed in 2020 euros.Results: Fifty‐one patients met the inclusion criteria (27 OW‐HTO and 24 CW‐HTO). Good to excellent functional outcomes, significant pain reduction (>6 points) and high patient satisfaction (>9/10) were observed in both groups. Both techniques yielded excellent radiological outcomes. N.s. differences in functional or radiological outcomes improvements between both procedures were found. However, the OW‐HTO group presented a higher total cost than the CW‐HTO group (4612.1 ± 765.6€ vs. 1827.1 ± 701.9€; p < 0.001). The cost‐effectiveness ratio was 818.1 ± 46.8 €/MCID for the CW‐HTO procedure and 2414.3 ± 115.2 €/MCID for the OW‐HTO procedure (p = 0.025).Conclusion: The CW‐HTO procedure presented a cost‐effectiveness ratio almost three times lower than the OW‐HTO procedure. Both techniques allowed to achieve of good to excellent functional outcomes, significant pain reduction and high patient satisfaction while correcting the varus limb malalignment and the metaphyseal tibial varus in patients with medial compartment osteoarthritis.Level of Evidence: Level III; economic study.
- 1 January 1991
- Published by S. Karger AG in Chemotherapy
- Vol. 37 (6) , 420-425
Postantibiotic Effect of Ciprofloxacin Compared with that of Five Other Quinolones
The antimicrobial activity (minimal inhibitory concentration, MIC, and killing kinetics) and postantibiotic effect (PAE) of different concentrations (MIC and 6 mg/1) of ciprofloxacin, norfloxacin, ofloxacin, pefloxacin, fleroxacin and lomefloxacin on pure cultures of Staphylococcus aureus and Escherichia coli were compared in vitro. The MIC, killing kinetics and PAE were determined by standard methods. Ciprofloxacin displayed the lowest MICs, while the highest were those of norfloxacin against S. aureus and lomefloxacin against E. coli. The killing curves showed ciprofloxacin to be the most and norfloxacin the least active. The bactericidal power was dependent on the concentration. At MIC, the fluoroquinolones, with the exception of norfloxacin, induced PAEs of 1-2 h. The effect was, in all cases, greater against E. coli. When assayed at 6 mg/l the PAEs were increased to 2-5 h, the best results being obtained by ciprofloxacin followed by ofloxacin. Norfloxacin produced no PAE on S. aureus and scarcely reached 1.3 h against E. coli. There was a close relationship between bactericidal power and PAE.
- 1 January 1991
- Published by S. Karger AG in Chemotherapy
- Vol. 37 (6) , 420-425
Postantibiotic Effect of Ciprofloxacin Compared with that of Five Other Quinolones
The antimicrobial activity (minimal inhibitory concentration, MIC, and killing kinetics) and postantibiotic effect (PAE) of different concentrations (MIC and 6 mg/1) of ciprofloxacin, norfloxacin, ofloxacin, pefloxacin, fleroxacin and lomefloxacin on pure cultures of Staphylococcus aureus and Escherichia coli were compared in vitro. The MIC, killing kinetics and PAE were determined by standard methods. Ciprofloxacin displayed the lowest MICs, while the highest were those of norfloxacin against S. aureus and lomefloxacin against E. coli. The killing curves showed ciprofloxacin to be the most and norfloxacin the least active. The bactericidal power was dependent on the concentration. At MIC, the fluoroquinolones, with the exception of norfloxacin, induced PAEs of 1-2 h. The effect was, in all cases, greater against E. coli. When assayed at 6 mg/l the PAEs were increased to 2-5 h, the best results being obtained by ciprofloxacin followed by ofloxacin. Norfloxacin produced no PAE on S. aureus and scarcely reached 1.3 h against E. coli. There was a close relationship between bactericidal power and PAE.